Pollack Danil 4
4 · Bespoke Extracts, Inc. · Filed Nov 1, 2021
Insider Transaction Report
Form 4
Pollack Danil
DirectorCEO10% Owner
Transactions
- Sale
Series C Preferred Stock
2021-10-28−1→ 0 total - Sale
Common Stock
2021-10-28$0.00/sh−50,000,000$40,000→ 76,000,000 total
Footnotes (1)
- [F1]On October 28, 2021, the Reporting Person entered into a stock purchase agreement with a third party for the sale by the Reporting Person of 50,000,000 shares of common stock and 1 share of Series C Preferred Stock of the Issuer for an aggregate purchase price of $40,000. The closing of the sale is subject to certain conditions set forth in the purchase agreement, including the filing and mailing of a Schedule 14f at least 10 days prior to closing.